Morgan Stanley lowers Ovintiv price target to $65

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Morgan Stanley analyst Devin McDermott maintains an Equal-Weight rating on Ovintiv and lowers the price target to $65 from $68, indicating a revised expectation for the stock.

powered bylight_fuzz_icon
44303182

*this image is generated using AI for illustrative purposes only.

Morgan Stanley analyst Devin McDermott has maintained an Equal-Weight rating on Ovintiv while lowering the price target to $65 from $68. The revised target suggests a tempered outlook for the company's stock performance.

The rating decision indicates that the stock is expected to perform in line with the broader market. Ovintiv is listed on the NYSE under the ticker symbol OVV.

Metric Value
Rating Equal-Weight
Previous Price Target $68
New Price Target $65
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors contributed to the decision to lower Ovintiv's price target despite maintaining an Equal-Weight rating?

How might Ovintiv's performance compare to its peers in the energy sector given the revised outlook?

What are the potential risks or opportunities that could influence Ovintiv's stock performance in the coming quarters?

like16
dislike